General MedicationsORALGeneric
MIDAZOLAM HYDROCHLORIDE
MIDAZOLAM HYDROCHLORIDE
Standard Dose
EQ 2MG BASE/ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary
Approval overview MIDAZOLAM HYDROCHLORIDE is listed in Drugs@FDA under application 077115 (ANDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient MIDAZOLAM HYDROCHLORIDE Form and strength SYRUP;ORAL - EQ 2MG BASE/ML Sponsor PHARM ASSOC Submission history Latest submission status date: 2023-01-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview MIDAZOLAM HYDROCHLORIDE is listed in Drugs@FDA under application 077115 (ANDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient MIDAZOLAM HYDROCHLORIDE Form and strength SYRUP;ORAL - EQ 2MG BASE/ML Sponsor PHARM ASSOC Submission history Latest submission status date: 2023-01-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.